Aldehyde Sequestering Agents for Hangover Symptom Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a safe and effective compound to prevent or treat hangover symptoms associated with the consumption of alcoholic beverages, particularly by reducing blood aldehyde buildup, and to address the Asian flushing syndrome and cardiovascular risks associated with ALDH2 deficiency.
Innovation Solution
Administration of an aldehyde sequestering agent, such as cysteine moieties like cysteinyiglycine (CG) or cystinyl-bis-glycine (CbG), which can form cyclic thiazolidine derivatives with aldehydes, thereby reducing their toxicity and facilitating their excretion, along with agents that increase ALDH2 activity, like taurine, alpha-lipoic acid, and sulforaphane.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If alcohol dehydrogenase metabolizes alcohol to acetaldehyde, then alcohol is eliminated from the body, but toxic acetaldehyde accumulates causing hangover symptoms and Asian flushing syndrome
Solution Approach 1:
The patent introduces aldehyde dehydrogenase (ALDH) as an intermediary substance that mediates the conversion of toxic acetaldehyde to less harmful acetate. This enzyme acts as a bridge between the harmful acetaldehyde and the safe end product, resolving the contradiction by adding a metabolic step that eliminates toxicity while maintaining alcohol elimination efficiency
Solution Approach 2:
The patent changes the biochemical parameters of acetaldehyde metabolism by introducing ALDH, which alters the reaction pathway from acetaldehyde accumulation to acetate production. This parameter change in the metabolic pathway transforms the toxic state into a safe state, allowing continuous alcohol metabolism without harmful side effects
2Reliability
If aldehyde dehydrogenase activity is increased to clear acetaldehyde faster, then hangover symptoms are reduced, but the complexity of metabolic regulation increases
Solution Approach 1:
The patent utilizes the body's own enzymatic systems (ALDH) to clear acetaldehyde, allowing the metabolic pathway to self-regulate without external intervention. The enzyme automatically converts acetaldehyde to acetate based on substrate availability, providing a simple, self-service mechanism that maintains reliability without adding regulatory complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed solution effectively reduces hangover symptoms, attenuates facial flushing, and decreases the risk of cardiovascular disease by sequestering toxic aldehydes and enhancing the metabolic clearance of acetaldehyde, thereby providing a natural and dietary supplement-based approach to mitigate the adverse effects of alcohol consumption.
Implementation Method 1
aldehyde dehydrogenase (ALDH) to convert them to their corresponding carboxylic acids
Implementation Method 2
cysteine moieties like cysteinyiglycine (CG) or cystinyl-bis-glycine (CbG), which can form cyclic thiazolidine derivatives with aldehydes
Implementation Method 3
acetaldehyde, the first oxidation product of ethanol itself
Data Source
AI summary
The invention provides methods for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s) in a subject comprising administering an aldehyde sequestering agent so as to reduce or counter blood aldehyde buildup in the subject, thereby preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s) in the subject.